Skip to main content

Market Overview

20 Stocks Moving in Monday's Pre-Market Session

Share:
20 Stocks Moving in Monday's Pre-Market Session

Gainers

  • Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer.
  • SemiLEDs Corporation (NASDAQ: LEDS) rose 25.8% to $10.01 in pre-market trading after dropping 22% on Friday.
  • Protagenic Therapeutics, Inc. (NASDAQ: PTIX) rose 19.3% to $2.54 in pre-market trading after climbing 14% on Friday.
  • American Shared Hospital Services. (NYSE: AMS) rose 11.1% to $3.79 in pre-market trading after dipping around 18% on Friday.
  • Cinedigm Corp. (NASDAQ: CIDM)shares rose 10.4% to $1.36 in pre-market trading. Cinedigm said ad sales surged 47% since deploying Amagi.
  • BioNTech SE (NASDAQ: BNTX) rose 9.4% to $200.97 in pre-market trading after the company announced plans to build headquarters for SE Asia, its first mRNA manufacturing facility in Singapore.
  • Acasti Pharma Inc. (NASDAQ: ACST) shares rose 8.1% to $0.5099 in pre-market trading. Acasti Pharma shares jumped over 16% on Friday after the company announced it will acquire Grace Therapeutics.
  • Property Solutions Acquisition Corp. (NASDAQ: PSAC) rose 8% to $12.15 in pre-market trading.
  • MoneyGram International, Inc. (NASDAQ: MGI) rose 7.1% to $8.60 in pre-market trading. MoneyGram shares jumped around 23% on Friday after the company reported better-than-expected Q1 sales results.
  • Vale S.A. (NYSE: VALE) shares rose 6.8% to $23.58 in pre-market trading.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) rose 6.6% to $7.30 in pre-market trading.
  • Orphazyme A/S (NASDAQ: ORPH) shares rose 6.1% to $6.10 in pre-market trading. Orphazyme recently announced that the ORARIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) did not meet its primary and secondary endpoints.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Soligenix, Inc. (NASDAQ: SNGX) fell 25% to $0.9608 in pre-market trading.
  • LM Funding America, Inc. (NASDAQ: LMFA) fell 10.3% to $4.01 in pre-market trading. The company, last week, announced a 1-for-5 reverse stock split.
  • InnSuites Hospitality Trust (NYSE: IHT) shares fell 8.6% to $3.20 in pre-market trading. InnSuites Hospitality Trust shares jumped 43% on Friday on above-average volume.
  • Aileron Therapeutics, Inc. (NASDAQ: ALRN) fell 6.7% to $1.11 in pre-market trading after gaining over 7% on Friday.
  • Regional Health Properties, Inc. (NYSE: RHE) fell 6.1% to $17.46 in pre-market trading after jumping 24% on Friday.
  • BioLineRx Ltd. (NASDAQ: BLRX) fell 5.9% to $3.50 in pre-market trading. BioLineRx, last week, announced positive top-line results from GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, combined with granulocyte colony-stimulating factor (G-CSF), for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.
  • Orgenesis Inc. (NASDAQ: ORGS) fell 5.7% to $5.34 in pre-market trading. Orgenesis shares climbed over 24% on Friday after the company swung to a Q1 profit.
  • SuperCom Ltd. (NASDAQ: SPCB) shares fell 5.1% to $1.31 in pre-market trading. The company, last week, announced it won a new project in California valued at up to $4 million.
 

Related Articles (ALF + ACST)

View Comments and Join the Discussion!

Posted-In: Pre-Market MoversNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com